BRUKER CORPORATION Business Combination, Consideration Transferred
BRUKER CORPORATION (BRKR) reported Business Combination, Consideration Transferred of $81.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2026-08-05
- BRUKER CORPORATION business combination, consideration transferred for the quarter ending 2026-06-30 was $100.00K.
- BRUKER CORPORATION business combination, consideration transferred for the quarter ending 2026-03-31 was $81.00M.
- BRUKER CORPORATION business combination, consideration transferred for the quarter ending 2025-12-31 was $4.10M, a 81.61% decline year-over-year.
- BRUKER CORPORATION business combination, consideration transferred for the quarter ending 2025-09-30 was $500.00K, a 61.54% decline year-over-year.
- BRUKER CORPORATION business combination, consideration transferred for fiscal 2024 was $137.70M, a 42.99% increase from fiscal 2023.
- BRUKER CORPORATION business combination, consideration transferred for fiscal 2023 was $96.30M, a 259.33% increase from fiscal 2022.
- BRUKER CORPORATION business combination, consideration transferred for fiscal 2022 was $26.80M, a 86.11% increase from fiscal 2021.
- BRUKER CORPORATION business combination, consideration transferred for fiscal 2021 was $14.40M.
| Period end | Business Combination, Consideration Transferred | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month | Business Combination, Consideration Transferred 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $81.10M 10-Q · filed 2026-08-05 | $85.20M derived: sum of 3 quarters · filed 2026-08-05 | $85.70M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $81.00M 10-Q · filed 2026-05-07 | $85.10M derived: sum of 2 quarters · filed 2026-05-07 | $85.60M derived: sum of 3 quarters · filed 2026-05-07 | |||
| 2025-12-31 | $4.10M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-07 | $4.60M derived: sum of 2 quarters · filed 2026-05-07 | $109.60M 10-Q · filed 2026-05-07 | $109.50M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $105.50M 10-Q · filed 2025-11-05 | ||||
| 2025-06-30 | $105.00M 10-Q · filed 2025-08-06 | |||||
| 2024-12-31 | $22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.60M derived: sum of 2 quarters · filed 2026-02-27 | $95.80M derived: sum of 3 quarters · filed 2026-02-27 | $137.70M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $73.50M derived: sum of 2 quarters · filed 2024-11-07 | $115.40M 10-Q · filed 2024-11-07 | $167.90M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2024-06-30 | $72.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $114.10M 10-Q · filed 2024-08-09 | $166.60M derived: sum of 3 quarters · filed 2025-03-03 | $183.70M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2024-03-31 | $41.90M 10-Q · filed 2024-05-10 | $94.40M derived: sum of 2 quarters · filed 2025-03-03 | $111.50M derived: sum of 3 quarters · filed 2025-03-03 | $111.50M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-12-31 | $52.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $69.60M derived: sum of 2 quarters · filed 2025-03-03 | $69.60M derived: sum of 3 quarters · filed 2025-03-03 | $96.30M 10-K · filed 2025-03-03 | $44.70M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $17.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $17.10M derived: sum of 2 quarters · filed 2024-11-07 | $43.80M 10-Q · filed 2024-11-07 | $51.30M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $26.70M 10-Q · filed 2024-08-09 | $34.20M derived: sum of 3 quarters · filed 2024-08-09 | $34.20M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $26.70M 10-Q · filed 2024-05-10 | $34.20M derived: sum of 2 quarters · filed 2024-05-10 | $34.20M derived: sum of 3 quarters · filed 2024-05-10 | $43.70M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.50M derived: sum of 2 quarters · filed 2024-02-29 | $17.00M derived: sum of 3 quarters · filed 2024-02-29 | $26.80M 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $9.50M derived: sum of 2 quarters · filed 2022-11-04 | $19.30M 10-Q · filed 2022-11-04 | |||
| 2022-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $19.30M 10-Q · filed 2022-08-05 | ||||
| 2022-03-31 | $9.80M 10-Q · filed 2022-05-06 | |||||
| 2021-12-31 | $14.40M 10-K · filed 2023-03-01 | $4.50M 10-K · filed 2022-02-28 | ||||
| 2021-11-17 | $14.40M 10-K · filed 2022-02-28 | |||||
| 2018-10-15 | $6.10M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |